CCL2 and breast carcinoma: Consistent with our results, other reports have shown that treatment with a CCL2-neutralizing antibody or genetic knockout of CCL2 suppresses lung metastasis, but not primary tumor growth, in in vivo models involving mouse and human breast cancer cells [28].